From drug target to lead molecules — computational solutions in translational research

webinar

Mon, 02 Dec 2013, 17:00 CET (Berlin)

From drug target to lead molecules — computational solutions in translational research

Turning early stage discoveries in cell and molecular biology into small molecule tool compounds and drug-like leads is a significant challenge, especially when resources are limited. We will show how you can fast-track your translational research using computational tools to analyze targets, hunt for data, identify potential small molecule binding pockets, and find active molecules. Leverage your know-how and take the first steps in drug discovery with us!

Current news

Entering The Trillion Era: AMBrosia Update
October 7, 2026 13:24 CEST
More chemistry. Trillions of possibilities. AMBrosia enters its third version with more than 2.4 trillion virtual product molecules. Developed in close collaboration with Ambinter (a brand of Greenpharma), the expanded Chemical Space combines 313,777 building blocks through 54 chemical reactions, implemented as 131 technical reactions, opening up a wealth of...
Read on
category
Events
DrugSpace 2026 Symposium - The Path to Digital Chemistry
October 6, 2026 11:28 CEST
Where Medicinal and Computational Chemistry Come Together We are delighted to invite drug hunters, compound enthusiasts, and molecule designers back to the virtual DrugSpace Symposium. The fifth edition takes place on December 9, 2026, under the theme “The Path to Digital Chemistry,” and turns the spotlight on where computational and...
Read on
category
Events
BioSolveIT at the Enamine Drug Discovery Conference 2026 in Riga
September 23, 2026 16:21 CEST
The Enamine Drug Discovery Conference in Riga (Latvia) comes to a close today. Our CEO Dr. Christian Lemmen and our SVP Application Science Dr. Marcus Gastreich spent the past four days, 20 to 23 September 2026, at the Radisson Blu Latvija Conference & Spa Hotel, and they return with much...
Read on